Xun Cao

777 total citations
45 papers, 505 citations indexed

About

Xun Cao is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Xun Cao has authored 45 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Surgery and 14 papers in Otorhinolaryngology. Recurrent topics in Xun Cao's work include Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (12 papers) and Esophageal Cancer Research and Treatment (10 papers). Xun Cao is often cited by papers focused on Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (12 papers) and Esophageal Cancer Research and Treatment (10 papers). Xun Cao collaborates with scholars based in China, Belgium and United States. Xun Cao's co-authors include Zhesheng Wen, Yujing Han, Yong Li, Mu‐Sheng Zeng, Zhe-Sheng Wen, Liru He, Lihong Zhou, Xin Wang, Kui‐Yuan Liu and Lin Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xun Cao

43 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xun Cao China 16 215 158 146 135 131 45 505
Peiguo Wang China 13 187 0.9× 82 0.5× 90 0.6× 96 0.7× 110 0.8× 44 493
Mingwei Zhang China 14 151 0.7× 174 1.1× 197 1.3× 115 0.9× 128 1.0× 42 543
Seung Ho Choi South Korea 11 123 0.6× 93 0.6× 57 0.4× 94 0.7× 42 0.3× 26 322
Hsueh‐Ju Lu Taiwan 12 121 0.6× 112 0.7× 88 0.6× 72 0.5× 78 0.6× 44 381
Maria Gebre‐Medhin Sweden 9 80 0.4× 113 0.7× 122 0.8× 68 0.5× 51 0.4× 18 371
Handan Kaya Türkiye 16 146 0.7× 156 1.0× 52 0.4× 75 0.6× 160 1.2× 48 536
Daniela Paccagnella Italy 8 84 0.4× 150 0.9× 81 0.6× 110 0.8× 54 0.4× 11 361
Daixing Hu China 15 250 1.2× 116 0.7× 182 1.2× 151 1.1× 169 1.3× 40 605
Yinong Niu China 12 143 0.7× 65 0.4× 199 1.4× 127 0.9× 59 0.5× 52 444

Countries citing papers authored by Xun Cao

Since Specialization
Citations

This map shows the geographic impact of Xun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xun Cao more than expected).

Fields of papers citing papers by Xun Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xun Cao. The network helps show where Xun Cao may publish in the future.

Co-authorship network of co-authors of Xun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xun Cao. A scholar is included among the top collaborators of Xun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xun Cao. Xun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Jiaqing, et al.. (2025). Analysis of the causes of poor incision healing after hip and knee surgery and review of the literature. BMC Musculoskeletal Disorders. 26(1). 166–166.
2.
Cao, Xun, Han-Ying Huang, Jiayu Zhou, et al.. (2025). Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial. Clinical Cancer Research. 31(15). 3133–3141. 1 indexed citations
3.
Qin, Peipei, et al.. (2025). Efficacy of Different Acupuncture Therapies for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Network Meta-Analysis. Journal of Pain Research. Volume 18. 3653–3673.
4.
Cao, Xun, Jiayu Zhou, Xi Chen, et al.. (2024). Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nature Communications. 15(1). 949–949. 5 indexed citations
5.
Cao, Xun, Yingying Huang, Ying Deng, et al.. (2024). Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence area. Radiotherapy and Oncology. 197. 110324–110324. 6 indexed citations
6.
Deng, Ying, Yingying Huang, Xun Cao, et al.. (2024). Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study. International Journal of Cancer. 156(1). 174–185. 2 indexed citations
7.
Li, Chengcheng, et al.. (2024). Knockdown of S100A2 inhibits the aggressiveness of endometrial cancer by activating STING pathway. Journal of Obstetrics and Gynaecology. 44(1). 2361849–2361849. 1 indexed citations
9.
Chen, Xi, Yingxue Li, Xun Cao, et al.. (2023). Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma. Lipids in Health and Disease. 22(1). 81–81. 5 indexed citations
11.
Cao, Xun, Xiao Zhou, Xiaomin Liu, & Lihong Zhou. (2016). Liraglutide alters DPP4 in the circumvallate papillae of type 2 diabetic rats. Journal of Molecular Endocrinology. 57(1). 13–21. 5 indexed citations
12.
Cao, Yang, Xun Cao, & Xiao-Min Liu. (2015). Expression of cholecystokinin2-receptor in rat and human L cells and the stimulation of glucagon-like peptide-1 secretion by gastrin treatment. Acta Histochemica. 117(2). 205–210. 15 indexed citations
15.
Meng, Yuqi, Xun Cao, Zhesheng Wen, et al.. (2013). Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma. Diseases of the Esophagus. 27(7). 670–677. 8 indexed citations
17.
Cao, Xun, Yong Li, Rong-Zhen Luo, et al.. (2012). Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery. 93(5). 1674–1680. 26 indexed citations
18.
Cao, Xun, Lin Zhang, Juan Yang, et al.. (2012). Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma. Journal of Translational Medicine. 10(1). 197–197. 34 indexed citations
19.
Cao, Xun, Yujing Han, Liru He, Jin Xiang, & Zhesheng Wen. (2011). Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: Who will benefit from combined treatment?. Oral Oncology. 47(8). 747–752. 26 indexed citations
20.
Cao, Xun, Rongzhen Luo, Liru He, et al.. (2011). Prognosticators and Risk Grouping in Patients with Lung Metastasis from Nasopharyngeal Carcinoma: A more accurate and appropriate assessment of prognosis. Radiation Oncology. 6(1). 104–104. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026